Immuneering Corp Company Insiders
| IMRX Stock | USD 2.13 0.08 3.90% |
Immuneering Corp employs about 66 people. The company is managed by 14 executives with a total tenure of roughly 154 years, averaging almost 11.0 years of service per executive, having 4.71 employees per reported executive. Break down of Immuneering Corp's management performance can provide insight into the company performance.
Immuneering |
Immuneering Corp Management Team Effectiveness
The company has return on total asset (ROA) of (0.3742) % which means that it has lost $0.3742 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6181) %, meaning that it created substantial loss on money invested by shareholders. Immuneering Corp's management efficiency ratios could be used to measure how well Immuneering Corp manages its routine affairs as well as how well it operates its assets and liabilities.Immuneering Corp Workforce Comparison
Immuneering Corp is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,460. Immuneering Corp holds roughly 66.0 in number of employees claiming about 5% of equities under Health Care industry.
Immuneering Corp Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Immuneering Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Immuneering Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Immuneering Corp insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Immuneering Corp Notable Stakeholders
An Immuneering Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Immuneering Corp often face trade-offs trying to please all of them. Immuneering Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Immuneering Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| MS MBA | CoFounder Emeritus | Profile | |
| Dr MBA | President CoFounder | Profile | |
| Paula CPA | Director Controller | Profile | |
| Praveen Nair | Head VP | Profile | |
| Mallory CPA | Principal Fin | Profile | |
| Mohamedi MBA | Head Devel | Profile | |
| Leah Neufeld | Chief Officer | Profile | |
| Brett Hall | Chief Officer | Profile | |
| Harold Brakewood | Chief Officer | Profile | |
| Scott MD | Chief Officer | Profile | |
| Peter King | Head VP | Profile | |
| Michael JD | Chief Secretary | Profile | |
| MBA MBA | President, CoFounder | Profile | |
| Rajaraman Krishnan | Head Discovery | Profile |
About Immuneering Corp Management Performance
The success or failure of an entity such as Immuneering Corp often depends on how effective the management is. Immuneering Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Immuneering management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Immuneering management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited. Immuneering Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 74 people.
Please note, the imprecision that can be found in Immuneering Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Immuneering Corp. Check Immuneering Corp's Beneish M Score to see the likelihood of Immuneering Corp's management manipulating its earnings.
Immuneering Corp Workforce Analysis
Traditionally, organizations such as Immuneering Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Immuneering Corp within its industry.Immuneering Corp Manpower Efficiency
Return on Immuneering Corp Manpower
| Revenue Per Employee | 6.89 | |
| Revenue Per Executive | 32.5 | |
| Net Loss Per Employee | 810.2K | |
| Net Loss Per Executive | 3.8M | |
| Working Capital Per Employee | 1.2M | |
| Working Capital Per Executive | 5.8M |
Additional Tools for Immuneering Stock Analysis
When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.